(R. typhi) Wilmington strain. This ESS preparation adsorbed to both human RBC and RRBC as demonstrated by titration of a positive serum. The highest dilution of ESS which affected complete sensitization of both RBC was 1:50. The diluent was Alsever solution.
Based on the demonstration that ESS adsorbed to RRBC, an attempt was made to raise anti-ESS antibody with ESS-RRBC as the immunogen. Each of four New Zealand white rabbits (Bar F Rabbitry, Virginia) was immunized with autologous RBC sensitized with ESS diluted 1:25. The ESS-RRBC were washed twice in Alsever solution, made up to 10%, and thoroughly mixed with an equal volume of complete adjuvant (H37Rv, Difco Laboratories, Detroit, Mich.). Each animal received the autologous mixture as follows: 2 ml in the right thigh, 2 ml in the left thigh, and 2 ml intraperitoneally. Each animal was boosted at 7 and 14 days after primary immunization with 3 ml of freshly prepared autologous 10% ESS-RRBC given intravenously without adjuvant. The animals were bled before immunization and 7, 14, and 21 days after primary immunization.
The procedures and antigens employed for the complement fixation (1, 7, 10) and microagglutination (6) The specificity of the anti-ESS response was further confirmed by inhibition of passive hemagglutination (ESS-RRBC) by free ESS with serum from a rabbit that showed the highest antibody response (1:1,024) at 21 days after primary immunization. A block titration was carried out so that serial twofold dilutions of the serum were titrated against serial twofold dilutions of the free ESS. After incubation at room temperature for 30 min, the sensitized RRBC were added, and the test was read after overnight incubation at room temperature. The results recorded in Fig. 1 show that soluble ESS specifically inhibits passive hemagglutination with ESS-RRBC.
Because rabbits inoculated with ESS-RRBC were found to develop antibodies not only to the homologous R. mooseri antigens but also to Proteus antigens, the absorption experiments recorded in Table 2 were conducted with serum collected 21 days after immunization to determine whether immunization with ESS-RRBC elicited a mixture of antibodies with separate specificities or a cross-reacting antibody. These results suggest that the antibodies detected by the ESS-RRBC agglutination reaction differ from those responsible for the Weil-Felix reaction and further suggest that the antibodies which are capable of agglutinating Proteus OX-19 differ from those which react with Proteus OX-2.
Although the boiling in 0.2 N NaOH employed to produce ESS probably destroys many rickettsial antigens, the fact that the immunization of rabbits with ESS-RRBC elicits the formation of antibodies which react not only in the homologous passive hemagglutination test but also in agglutination tests with Proteus OX-19 and Proteus OX-2 suggests that the ESS preparation contained more than one antigenic determinant. 
